TP53BP2 (human), recombinant protein

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
ABS-PP-6104-L.20	20 µg	-	-	-	10 - 15 business days*		115.00€
ABS-PP-6104-L.100	100 µg	-	-	-	10 - 15 business days*		205.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Protein function: Regulator that plays a central role in regulation of apoptosis and cell growth... more

Close menu

Product information "TP53BP2 (human), recombinant protein"

Protein function: Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions with proteins such as TP53 (PubMed:12524540). Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of APPBP1 to conjugate NEDD8 to CUL1, and thereby decreases APPBP1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42. [The UniProt Consortium]

Keywords:	Apoptosis-stimulating of p53 protein 2, Bcl2-binding protein, Bbp, Renal carcinoma antigen NY-REN-51, Tumor suppressor p53-binding protein 2, 53BP2, p53-binding protein 2, p53BP2, Recombinant Human TP53BP2 Protein
Supplier:	Absea
Supplier-Nr:	PP-6104-L

Properties

Conjugate:	No
Host:	E.coli
Species reactivity:	human
MW:	48.5 kD
Format:	Lyophilized

Database Information

KEGG ID :	K16823 \| Matching products
UniProt ID :	Q13625 \| Matching products
Gene ID :	GeneID 7159 \| Matching products

Handling & Safety

Storage:	-20°C (protect from light & moisture)
Shipping:	+20°C (International: +20°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "TP53BP2 (human), recombinant protein"

Write a review